Q3 2025 Inspire Medical Systems Inc Earnings Call Transcript
Key Points
- Inspire Medical Systems Inc (INSP) reported a 10% increase in third-quarter revenue, totaling $224.5 million, compared to the prior year period.
- The company achieved a gross margin of 85.8%, up from 84.1% in the previous year, primarily due to increased sales volume and a favorable sales mix of Inspire 5.
- Inspire 5 system has shown strong clinical performance, with significant improvements in patient outcomes and a reduction in surgical times.
- The company has made significant progress in the US launch of Inspire 5, with over 98% of physician training complete and over 75% of centers implanting the new system.
- Inspire Medical Systems Inc (INSP) increased its earnings per share guidance for the full year 2025 to $0.90 to $1, up from the previous range of $0.40 to $0.50.
- Operating expenses increased by 17% compared to the third quarter of 2024, primarily due to increased patient marketing expenses and general corporate costs.
- Net income for the quarter decreased to $9.9 million from $18.5 million in the prior year period.
- The adjusted EBITDA margin decreased to 20% from 22% in the third quarter of 2024.
- The company is facing legal fees related to a civil investigative demand from the Department of Justice and patent infringement lawsuits.
- There is ongoing uncertainty regarding the impact of new competitors and the introduction of GLP-1 therapies on the market growth and Inspire's future performance.
Good afternoon. My name is Delem, and I'll be your conference operator today. At this time, I'd like to welcome everyone to the Inspire Medical System's third-quarter 2025 conference call. (Operator Instructions)
I now hand the call over to your first speaker, Ezgi Yagci, the Vice President of Investor Relations at Inspire. You may begin the conference.
Thank you, Delem and thank you all for participating in today's call. Joining me are Tim Herbert, Chairman and Chief Executive Officer, and RickBuholz, Chief Financial Officer.
Earlier today, we released financial results for the 3 and 9 months ended September 30, 2025. A copy of the press release is available on our website.
On this call, management will make forward-looking statements within the meaning of the Federal securities laws. All forward-looking statements, including without limitation, those relating to our operations, financial results, and financial condition, investments in our business,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
